Clinical Trial Update: Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) [Phase 3]

View source ↗

Summary

Phase 3 trial update on colchicine for preventing perioperative atrial fibrillation in thoracic surgery patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: COMPLETED